Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Pathology and AI
AI model reveals kidney tumor features, potential for treatment response prediction
Researchers at the Dana-Farber Cancer Institute have trained artificial intelligence (AI) models to assess the clinical features of kidney cancer tumor samples to predict how tumors may respond to immune therapy.
September 22, 2023
NIH’s systematic review finds AI may improve detection of underdiagnosed condition
A systematic review of earlier studies has found that artificial intelligence (AI) and machine learning (ML) can support the diagnosis of polycystic ovarian syndrome (PCOS).
September 19, 2023
Ibex Medical Analytics launches AI-powered breast cancer biomarker scoring platform
Ibex Medical Analytics has launched a breast cancer biomarker scoring tool powered by artificial intelligence (AI) to help clinicians with treatment decisions.
September 11, 2023
Ginkgo Bioworks, Google Cloud to collaborate on AI tools
Ginkgo Bioworks and Google Cloud have entered into a strategic five-year strategic partnership to develop artificial intelligence (AI) tools for biology and biosecurity.
September 6, 2023
Lunit to present results of AI-based immunotherapy predictive test study at WCLC 2023
Lunit announced the presentation of data from a collaborative study on the use of the Lunit SCOPE IO test to predict immunotherapy treatment outcomes in lung cancer at the 2023 World Conference on Lung Cancer (WCLC 2023).
August 28, 2023
AI neuroimaging model aims to predict neuropathic pain treatment responses
A magnetic resonance (MR) neuroimaging model which uses artificial intelligence (AI) to identify new biomarkers could lead to more effective medical treatment for chronic nerve pain, say the researchers developing the model.
August 25, 2023
Gene-specific approach recommended for variant pathogenicity prediction
A research team investigated the efficacy of gene-specific supervised machine learning in predicting the pathogenicity of rare BRCA1/2 missense variants compared to the disease-specific approach.
August 22, 2023
AI system in development aims for earlier endometriosis diagnosis
IMAGENDO uses machine learning to digitally combine the diagnostic capabilities of pelvic scans and MRI to identify endometriosis lesions. The researchers are seeking to optimize and validate the algorithm.
August 21, 2023
BARDA commits $30.5M to the development of musculoskeletal imaging system
BARDA has committed funding to support the development of a device that could quickly triage fracture severity in the wake of a chemical, biological, radiological, or nuclear attack and thereby preserve x-ray resources for the highest-priority patients.
August 11, 2023
AI model traces cancers of unknown primary origin to their sources
In results from a study published recently in Nature, OncoNPC was able to accurately predict the origin of about 80% of the tumors tested, including metastatic disease.
August 8, 2023
Dr. Atul Butte calls for ‘new system of precision medicine’ in plenary lecture at AACC 2023
The computer scientist told attendees how data-driven initiatives have transformed medical practice at the University of California health system, and how the combination of EHRs and AI could identify ways to cut the costs of treating patients.
July 31, 2023
Molecular pathology bodies recommend expansion of pharmacogenomic test panels
In its latest project, the working group investigated clinical CYP3A4 and CYP3A5 PGx testing, leading the AMP and its collaborators to issue consensus recommendations on the genes.
July 18, 2023
Page 1 of 173
Next Page
